Intermittent Imatinib Treatment in Chronic Myeloid Leukemia and Philadelphia Chromosome (Ph+CML) Patients Who Achieved a Complete Cytogenetic Response (CCgR) on Standard Imatinib Therapy
Clinical trial NCT00858806 · COMPLETED
Trial details
- NCT number
- NCT00858806
- Sponsor
- Università degli Studi di Brescia
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2010-12-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.